Table 1 showed the correlation between miR-127 expression and clinicopathological factors of BC patients. By statistical analyses, low-miR-127 expression was found to be significantly correlated with higher incidence of lymph node metastasis and advanced clinical stage (P = 0.029 and 0.004, resp). . However, there were no significant correlations between miR-127 expression and other clinicopathological factors of patients, such as age, tumor size, histological type, differentiation grade, ER, PR, and HER-2 status (P = 0.749, 0.500, 0.795, 0.352, 0.936, 0.340, and 0.640, resp). Here, ERBB2 is linked to breast cancer.